Found 15 matching trials
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
EARLY_PHASE1This study is for adult patients with advanced melanoma who are receiving i...
Location
University of Virginia
Autologous OC-L Vaccine and Ovarian Cancer
PHASE1This is a randomized pilot trial to test the addition of 2 investigational ...
Location
Ovarian Cancer Research Center
Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients
NAThe primary objective of this study is to assess the safety and tolerabilit...
Location
Shanghai 10th People's Hospital
Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma
PHASE1This study evaluates whether it is safe to administer a peptide vaccine in ...
Location
Cancer Center at the University of Virginia
Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma
PHASE1This study evaluates whether it is safe to administer a peptide vaccine (6M...
Location
University of Virginia
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
PHASE1This study evaluates whether it is safe to Focused Ultrasound Ablation (FUS...
Location
University of Virginia
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
PHASE1The purpose of this study is to learn the effects an experimental vaccine (...
Location
University of Virginia
Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer
PHASE1The purpose of this study is to test an approach of stimulating the body's ...
Location
Icahn School of Medicine at Mount Sinai
Dendritic Cell Vaccine for Patients With Brain Tumors
PHASE2The main purpose of this study is to evaluate the most effective immunother...
Location
University of Los Angeles, California
Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies
PHASE1The purpose of this study is to learn what effects (good and bad) experimen...
Location
University of Virginia